Optos (Marlborough, MA) has built an ophthalmic technology around wide field diagnostic imaging of the fundus. With over 3,800 units installed worldwide, the Company’s devices have been used to capture over 15 million patient images to date. With the recent introduction of advanced risk based imaging, the Company has begun commercializing its technology to ophthalmology to complement its strong presence in optometry. SM2 Strategic was asked to conduct interviews with a group of ophthalmic surgeons who have incorporated the technology in their practices to better understand the utility of Optos in an MD practice. Further, the purpose of these interviews is to help ophthalmologists understand how this imaging technology differs from traditional methods of capturing data about the fundus. Finally, we wish to describe how the Optos device is influencing physician and patient behavior…
925.425.9900
info@sm2strategic.com
